Nasal responsiveness to allergen and histamine in patients with perennial rhinitis with and without a late phase response

de Graaf-in't Veld, C.; Garrelds, I. M.; van Toorenenbergen, A. W.; van Wijk, R. Gerth
February 1997
Thorax;Feb1997, Vol. 52 Issue 2, p143
Academic Journal
No abstract available.


Related Articles

  • Allergic rhinitis: a review. Smith, Haley // South African Pharmaceutical Journal;2012, Vol. 79 Issue 8, p28 

    Allergic rhinitis is a common condition that occurs due to an inflammatory response that involves the release of histamine, which is initiated by allergens that are deposited on the nasal mucosa. Allergens that are responsible for seasonal allergic rhinitis include grass pollens, tree pollens...

  • THE ANTIINFLAMMATORY EFFECT OF H1 ANTIHISTAMINES IN ALLERGIC RHINITIS. Bocşan, Corina; Cristea, V. // Therapeutics, Pharmacology & Clinical Toxicology;2011, Vol. 15 Issue 1, p13 

    Allergic rhinitis is an immune inflammatory process, IgE mediated, which affects nasal mucosa. The immune allergic response presents 3 phases and involves many cells and mediators. Interleukins are involved both in producing and maintaining this process. Il-1, Il-6 and TNF-a increase allergic...

  • Mast Cell Stabilizers in the Treatment of Allergic Rhinitis. Can, Ilknur Haberal; Samim, Ethem Erdal // Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry;Feb2008, Vol. 7 Issue 1, p9 

    Allergic rhinitis (AR) is caused by an immediate type hypersensitivity reaction in sensitized subjects after exposure to airborn allergens. The interaction of the allergen with a specific IgE antibody attached to the nasal mast cells leads to the local release of vasoactive and inflammatory...

  • Allergic rhinitis: Pathophysiology. Broide, David H. // Allergy & Asthma Proceedings;Sep/Oct2010, Vol. 31 Issue 5, p370 

    The inflammatory response in the nasal mucosa in subjects with allergic rhinitis challenged intranasally with an allergen includes an immediate IgE-mediated mast cell response as well as a late-phase response characterized by recruitment of eosinophils, basophils, and T cells expressing Th2...

  • EFFECTS OF CETIRIZINE ON SUBSTANCE P RELEASE IN PATIENTS WITH PERENNIAL ALLERGIC RHINITIS. Shirasaki, Hideaki; Kanaizumi, Etsuko; Narita, Shin-Ichirou; Watanabe, Kazumasa; Konno, Nobuhiro; Sato, Jun; Himi, Tetsuo // Annals of Otology, Rhinology & Laryngology;Dec2004, Vol. 113 Issue 12, p941 

    To evaluate the effect of cetirizine hydrochloride on substance P release in allergic rhinitis, we performed a single-blind placebo-controlled study of 14 patients with perennial allergic rhinitis (7 treated with cetirizine and 7 with placebo). After an initial nasal allergen challenge with...

  • Allergic Sensitization to Perennial Allergens in Adults and Children Sensitized to Japanese Cedar or Japanese Cypress Pollen in Japan. Masafumi Ohki; Masanobu Shinogami // International Journal of Otolaryngology;2014, p1 

    In Japan, seasonal allergic rhinitis in the spring due to exposure to Japanese cedar or Japanese cypress pollen is common. However, the allergic profile for perennial allergens in spring pollinosis remains unclear. Therefore, in this study, we investigated the allergic profiles of 652 patients...

  • 'S not any fun for children with allergic rhinitis. Adis International Limited // Drugs & Therapy Perspectives;Jun2005, Vol. 21 Issue 6, p7 

    Explores the effect of allergic rhinitis on children. Description of allergic rhinitis in children; Role of immunoglobulin E in nasal response to allergens; Factors considered in the diagnosis of rhinitis; Preventive strategy for allergens.

  • Treatment of Allergic Rhinitis in Children. Kilic, Gurkan // Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry;Feb2008, Vol. 7 Issue 1, p38 

    Allergic rhinitis is an inflammatory disease of nasal mucosa mediated by IgE-associated response to indoor and outdoor environmental allergens. The treatment of allergic rhinitis involves three main categories: avoidance of allergen, pharmacologic management and immunotherapy. The first...

  • The safety and efficacy of desloratadine for the management of allergic disease. Berger, William E. // Drug Safety;2005, Vol. 28 Issue 12, p1101 

    Allergic disease is an increasing problem worldwide. Allergic rhinitis, an inflammatory response to an allergen, affects an estimated 20–40 million people in the US, while chronic idiopathic urticaria is a dermatoallergic condition that affects 0.1–3% of people in the US and...

  • Efficacy of Montelukast in the Treatment of Nasal Polyposis.  // Annals of Otology, Rhinology & Laryngology;Dec2005, Vol. 114 Issue 12, p941 

    The article presents an evaluation for response to adjunctive oral montelukast sodium therapy on the patients suffering from symptomatic nasal polyposis and non allergic or perennial rhinitis and undergoing chronic nasal steroid therapy. The result of the evaluation depicted that for some...


Read the Article


Sign out of this library

Other Topics